Summary Background Data
Postgastrectomy anemia is due to deficiencies of iron and vitamin B 12 , and parenteral B 12 administration is the only appropriate treatment. However, no guidelines exist for the prophylactic use of B 12 in patients who undergo total gastrectomy, the clinical presentation of B 12 deficiency in this context has not been defined, and the question of whether oral B 12 administration can be used to prevent and treat B 12 deficiency has not been examined.
Methods
Serum B 12 concentrations were measured in 31 patients who had undergone total gastrectomy. Symptoms related to B 12 deficiency were surveyed in detail. Serum B 12 concentrations were measured every 6 months after total gastrectomy in 10 patients. Thirty one patients received supplemental B 12 : 18 patients orally and 13 by intramuscular injection.
Results
The B 12 concentration dropped below the lower limit of normal (200 pg/mL) for the first time in two patients at 1 year, in four patients at 2 years, in three patients at 3 years, and in one patient at 4 years. Seventy-eight percent of patients reported some symptoms related to B 12 deficiency. The serum B 12 concentration in patients who received supplemental B 12 orally increased rapidly and all symptoms resolved with oral therapy alone.
Conclusions
B 12 deficiency can develop as early as 1 year after total gastrectomy and causes symptoms. Because enteral B 12 treatment increases the serum B 12 concentration and leads to rapid resolution of symptoms, it should be prescribed routinely to patients undergoing total gastrectomy.
Anemia develops in 50% of patients who undergo total gastrectomy. 1 It is generally accepted that the only appropriate and effective therapy is the parenteral administration of vitamin B 12 . However, the clinical presentation of postgastrectomy B 12 deficiency has not been defined, nor has the role of supplemental B 12 therapy been standardized. In particular, the efficacy of oral B 12 administration has not been examined. We reviewed the records of patients who developed postoperative B 12 deficiency to establish its time course, delineate its symptoms, and evaluate the ability of oral B 12 administration to correct hypovitaminemia.
METHODS
One hundred thirty-five patients who underwent total gastrectomy for a gastric malignancy at our hospital between 1991 and 1996 survived at least 2 years. Thirty-one patients had B 12 deficiency documented by measurement of the serum B 12 concentration (Table 1) . These patients form the cohort of this study. Subjects included 23 men and 8 women with an average age of 57.2 years (range 38 -74). Eight patients underwent Roux-en-Y gastric reconstruction, 16 underwent pouch-Y reconstruction, and 7 patients underwent pouch interposition. Clinical symptoms were surveyed in detail. In 10 patients, the serum B 12 concentration was measured every 6 months after total gastrectomy to establish the time course of B 12 deficiency.
All patients received B 12 supplements once the deficiency was identified. B 12 was administered orally in 18 patients and by intramuscular injection in 13 patients. Changes in the serum B 12 concentration and in symptoms were recorded in both groups. The Student t test was used to compare the B 12 concentration before and after B 12 administration.
RESULTS
All 31 patients had B 12 deficiency. The B 12 deficiency was noted at the initial measurement in 21 patients: 5 at 1 year, 7 at 2 years, 3 at 3 years, 3 at 4 years, and 3 at 5 years. The time course of the change in the mean serum B 12 concentration among the 10 patients who were studied every 6 months after surgery is shown in Figure 1 . The mean B 12 concentration was below the lower limit of normal (200 pg/mL) for the first time in 2 patients at 1 year, 4 patients at 2 years, 3 patients at 3 years, and 1 patient at 4 years.
Patients with B 12 deficiency had a variety of signs and symptoms, including lassitude, fatigability, chills, numbness in the extremities (peripheral neuropathy), dizziness, glossitis, cervical leukoplakia, and erectile dysfunction. Of the 31 patients in the study, 24 (78%) had at least one symptom of B 12 deficiency. Twelve had fatigability (39%), 10 had cold feet or legs (32%), 4 had numbness (13%), 4 had dizziness (13%), and 1 each had glossitis, leukoplakia, or erectile dysfunction (3%).
The mean serum B 12 concentration among patients who received oral B 12 administration increased rapidly ( Table 2 ). Symptoms resolved comparably in patients who received enteral and parenteral B 12 therapy. No patient of the 31 was found to have Barrett esophagus by endoscopic study.
DISCUSSION
Vitamin B 12 deficiency can develop as early as 1 year after total gastrectomy before the onset of anemia. 2, 3 In this study, careful screening showed that 78% of patients who were deficient had at least one symptom, such as lassitude, fatigability, chills, peripheral neuropathy, 4 dizziness, glossitis, cervical leukoplakia, and erectile dysfunction, attributable to a lack of B 12 . These data present a compelling argument for the routine use of supplemental B 12 therapy after total gastrectomy.
The treatment of pernicious anemia resulting from B 12 deficiency has been thought to require parenteral B 12 administration. 5 However, enteral B 12 treatment increased the serum B 12 concentration in this study, and symptoms related to B 12 deficiency resolved rapidly. Intrinsic factor is neces- sary to absorb enteral B 12 , 6 which may be produced in the duodenum and jejunum after total gastrectomy. Because the type of reconstruction had no effect on B 12 absorption, passage of food through the duodenum does not appear to be necessary to absorb B 12 enterally. Barrett esophagus was not seen in any patients. 7 We currently are using animal models to localize the site where intrinsic factor is produced after total gastrectomy.
In conclusion, prophylactic enteral B 12 administration should be initiated immediately after total gastrectomy. This therapy is inexpensive, convenient, and effective and prevents symptoms associated with B 12 deficiency. 
